A 64-year-old female presents to her primary care physician for an annual checkup. She states that her health is adequate, but she has not been doing well since her husband died last year. She is able to get by but admits to having trouble caring for herself, cooking, cleaning, and paying her bills. The patient complains of diffuse muscle aches and pains. She has a past medical history of anxiety and seasonal affective disorder. She is not currently taking any medications. On physical exam, you note a gaunt woman with a depressed affect. You note that her body mass index (BMI) and height have both decreased since her last annual visit. On physical exam, her cardiac, pulmonary, and abdominal exams are within normal limits. Lab work is drawn and is as follows:
Serum:
Na+: 135 mEq/L
K+: 3.7 mEq/L
Cl-: 100 mEq/L
HCO3-: 23 mEq/L
Urea nitrogen: 7 mg/dL
Glucose: 70 mg/dL
Creatinine: 0.8 mg/dL
Ca2+: 8.0 mg/dL
Mg2+: 1.5 mEq/L
Parathyroid hormone: 855 pg/mL
Alkaline phosphatase: 135 U/L
Phosphorus: 2.6 mg/dL
Hemoglobin: 14 g/dL
Hematocrit: 36%
Platelet count: 187,000/mm^3
Leukocyte count: 4,700/mm^3
What is the most likely diagnosis?
Q22
A 57-year-old male is found to have an elevated prostate specific antigen (PSA) level on screening labwork. PSA may be elevated in prostate cancer, benign prostatic hypertrophy (BPH), or prostatitis. Which of the following best describes the physiologic function of PSA?
Q23
A 76-year-old woman presents to the office with a generalized weakness for the past month. She has a past medical history significant for uncontrolled hypertension and type 2 diabetes mellitus. Her temperature is 37.0°C (98.6°F), blood pressure is 135/82 mm Hg, pulse is 90/min, respiratory rate is 17/min, and oxygen saturation is 99% on room air. Physical exam shows no remarkable findings. Her last recorded glomerular filtration rate was 30 mL/min. A radiograph of the patient’s hand is given. Which of the following lab findings is most likely to be found in this patient?
Q24
A 23-year-old man presents to the office complaining of weight loss and fatigue for the past 2 months. He states that he has been experiencing foul-smelling, light-colored stools but thinks it is because he hasn’t been eating well, recently. He has a past medical history significant for cystic fibrosis, which is well-controlled medically. He denies any shortness of breath, chest or abdominal pain, nausea, vomiting, or melena. On physical examination, his skin is pale and dry. Which of the following would be the most likely etiology of a malabsorption syndrome giving rise to this patient’s current condition?
Q25
A healthy 30-year-old female has a measured creatinine clearance of 100 mL/min. She has a filtration fraction (FF) of 25%. Serum analysis reveals a creatinine level of 0.9 mg/dL and an elevated hematocrit of 0.6. Which of the following is the best estimate of this patient’s renal blood flow?
Q26
In a healthy patient with no renal abnormalities, several mechanisms are responsible for moving various filtered substances into and out of the tubules. Para-aminohippurate (PAH) is frequently used to estimate renal blood flow when maintained at low plasma concentrations. The following table illustrates the effect of changing plasma PAH concentrations on PAH excretion:
Plasma PAH concentration (mg/dL) | Urinary PAH concentration (mg/dL)
0 | 0
10 | 60
20 | 120
30 | 150
40 | 180
Which of the following mechanisms best explains the decreased rate of increase in PAH excretion observed when plasma PAH concentration exceeds 20 mg/dL?
Q27
A 10-year-old boy is brought to a pediatric clinic by his parents with pain and weakness in the lower extremities for the past 3 weeks. The patient’s mother says that he has been active until the weakness and pain started during his soccer practice sessions. He says he also experiences muscle cramps, especially at night. His mother adds that, recently, the patient constantly wakes up in the night to urinate and is noticeably thirsty most of the time. The patient denies any recent history of trauma to his legs. His vaccinations are up to date and his family history is unremarkable. His vital signs are within normal limits. Physical examination is unremarkable. Laboratory findings are shown below:
Laboratory test
Serum potassium 3.3 mEq/L
Serum magnesium 1.3 mEq/L
Serum chloride 101 mEq/L
pH 7.50
Pco2 38 mm Hg
HCO3- 20 mEq/L
Po2 88 mm Hg
Which of the following is the most likely diagnosis in this patient?
Q28
A 42-year-old man is brought to the emergency room because of confusion. His wife says he has been urinating more frequently than usual for the past 3 days. He has not had fever or dysuria. He has bipolar disorder, for which he takes lithium. His pulse is 105/min, and respirations are 14/min. He is lethargic and oriented only to person. Physical examination shows dry mucous membranes and increased capillary refill time. Laboratory studies show a serum sodium concentration of 158 mEq/L and an antidiuretic hormone (ADH) concentration of 8 pg/mL (N = 1–5). Which of the following is the most likely site of dysfunction in this patient?
Q29
An investigator is studying physiologic renal responses to common medical conditions. She measures urine osmolalities in different parts of the nephron of a human subject in the emergency department. The following values are obtained:
Portion of nephron Osmolality (mOsmol/kg)
Proximal convoluted tubule 300
Loop of Henle, descending limb 1200
Loop of Henle, ascending limb 250
Distal convoluted tubule 100
Collecting duct 1200
These values were most likely obtained from an individual with which of the following condition?
Q30
An investigator is studying the efficiency of a new anti-gout drug in comparison to colchicine in an experimental animal model. The test group of animals is injected with the new drug, while the control group receives injections of colchicine. Which of the following cellular functions will most likely be impaired in the control subjects after the injection?
Renal US Medical PG Practice Questions and MCQs
Question 21: A 64-year-old female presents to her primary care physician for an annual checkup. She states that her health is adequate, but she has not been doing well since her husband died last year. She is able to get by but admits to having trouble caring for herself, cooking, cleaning, and paying her bills. The patient complains of diffuse muscle aches and pains. She has a past medical history of anxiety and seasonal affective disorder. She is not currently taking any medications. On physical exam, you note a gaunt woman with a depressed affect. You note that her body mass index (BMI) and height have both decreased since her last annual visit. On physical exam, her cardiac, pulmonary, and abdominal exams are within normal limits. Lab work is drawn and is as follows:
Serum:
Na+: 135 mEq/L
K+: 3.7 mEq/L
Cl-: 100 mEq/L
HCO3-: 23 mEq/L
Urea nitrogen: 7 mg/dL
Glucose: 70 mg/dL
Creatinine: 0.8 mg/dL
Ca2+: 8.0 mg/dL
Mg2+: 1.5 mEq/L
Parathyroid hormone: 855 pg/mL
Alkaline phosphatase: 135 U/L
Phosphorus: 2.6 mg/dL
Hemoglobin: 14 g/dL
Hematocrit: 36%
Platelet count: 187,000/mm^3
Leukocyte count: 4,700/mm^3
What is the most likely diagnosis?
A. Hyperparathyroidism
B. Osteoporosis
C. Clinical malnutrition
D. Osteopenia
E. Osteomalacia (Correct Answer)
Explanation: ***Osteomalacia***
- This patient presents with **diffuse muscle aches and pains**, decreased BMI and height, and laboratory findings of **low calcium (8.0 mg/dL)**, **low phosphorus (2.6 mg/dL)**, and **elevated PTH (855 pg/mL)** and **alkaline phosphatase (135 U/L)**. These are classic signs of osteomalacia, which is often caused by **vitamin D deficiency** leading to impaired bone mineralization.
- The patient's inability to care for herself, cook, and clean following her husband's death may suggest **poor nutritional intake**, increasing her risk for vitamin D deficiency.
*Hyperparathyroidism*
- While **elevated PTH** is present, primary hyperparathyroidism typically causes **hypercalcemia**, not the hypocalcemia seen in this patient.
- Secondary hyperparathyroidism can occur in osteomalacia, but it is a compensatory response to low calcium and vitamin D, not the primary diagnosis.
*Osteoporosis*
- Osteoporosis is characterized by **reduced bone density** and increased fracture risk, but it does **not typically involve abnormal calcium, phosphorus, or PTH levels** in this pattern.
- The diffuse muscle aches and pains (myopathy) are more indicative of osteomalacia.
*Clinical malnutrition*
- While the patient exhibits signs of **malnutrition (decreased BMI, poor self-care)**, this is a contributing factor to the underlying bone disease, not the definitive diagnosis explaining the specific biochemical abnormalities.
- Malnutrition can predispose to osteomalacia due to **insufficient vitamin D intake**.
*Osteopenia*
- Osteopenia refers to **lower-than-normal bone mineral density** that is not as severe as osteoporosis.
- Similar to osteoporosis, osteopenia itself does not explain the **hypocalcemia, hypophosphatemia, and markedly elevated PTH** and alkaline phosphatase levels observed in this patient.
Question 22: A 57-year-old male is found to have an elevated prostate specific antigen (PSA) level on screening labwork. PSA may be elevated in prostate cancer, benign prostatic hypertrophy (BPH), or prostatitis. Which of the following best describes the physiologic function of PSA?
A. Regulation of transcription factors and phosphorylation of proteins
B. Maintains corpus luteum
C. Response to peritoneal irritation
D. Sperm production
E. Liquefaction of semen (Correct Answer)
Explanation: ***Liquefaction of semen***
- Prostate-specific antigen (PSA) is a **serine protease** produced by the epithelial cells of the prostate gland.
- Its primary physiological role is to **liquefy the seminal coagulum** formed after ejaculation, allowing sperm to become motile and navigate the female reproductive tract.
*Regulation of transcription factors and phosphorylation of proteins*
- This function is characteristic of **kinases** and **phosphatases**, which are involved in intracellular signaling pathways.
- While essential for cellular function, it does not describe the specific role of PSA.
*Maintains corpus luteum*
- The maintenance of the corpus luteum is primarily the role of **luteinizing hormone (LH)** and, in pregnancy, **human chorionic gonadotropin (hCG)**.
- These hormones are involved in the female reproductive cycle, unrelated to PSA.
*Response to peritoneal irritation*
- Peritoneal irritation triggers an inflammatory response involving various immune cells and mediators, but not specifically PSA.
- PSA itself is not directly involved in the systemic or local response to peritoneal inflammation.
*Sperm production*
- **Sperm production (spermatogenesis)** occurs in the seminiferous tubules of the testes under the influence of hormones like FSH and testosterone.
- While semen is the vehicle for sperm, PSA's role is in the post-ejaculatory processing of semen, not in the initial production of sperm.
Question 23: A 76-year-old woman presents to the office with a generalized weakness for the past month. She has a past medical history significant for uncontrolled hypertension and type 2 diabetes mellitus. Her temperature is 37.0°C (98.6°F), blood pressure is 135/82 mm Hg, pulse is 90/min, respiratory rate is 17/min, and oxygen saturation is 99% on room air. Physical exam shows no remarkable findings. Her last recorded glomerular filtration rate was 30 mL/min. A radiograph of the patient’s hand is given. Which of the following lab findings is most likely to be found in this patient?
A. Increased PTH, decreased calcium, increased phosphate (Correct Answer)
B. Increased PTH, decreased calcium, decreased phosphate
C. Normal PTH, increased calcium, normal phosphate
D. Increased PTH, increased calcium, decreased phosphate
E. Increased PTH, increased calcium, increased phosphate
Explanation: ***Increased PTH, decreased calcium, increased phosphate***
- The patient's **glomerular filtration rate (GFR) of 30 mL/min** indicates **Stage 4 chronic kidney disease (CKD)**. In CKD, the kidneys are unable to adequately excrete phosphate, leading to **hyperphosphatemia**.
- Hyperphosphatemia leads to the formation of calcium-phosphate complexes, causing a decrease in free calcium (hypocalcemia) by precipitating out. Additionally, damaged kidneys cannot convert vitamin D into its active form, which further reduces calcium absorption from the gut and bone, contributing to hypocalcemia. This persistent hypocalcemia stimulates the parathyroid glands to produce more **parathyroid hormone (PTH)**, resulting in **secondary hyperparathyroidism**.
*Increased PTH, decreased calcium, decreased phosphate*
- This pattern of laboratory findings is characteristic of **primary hyperparathyroidism**, where an adenoma or hyperplasia of the parathyroid glands leads to excessive PTH production.
- In primary hyperparathyroidism, elevated PTH causes increased bone resorption and renal phosphate excretion, typically resulting in **hypercalcemia** and **hypophosphatemia**.
*Normal PTH, increased calcium, normal phosphate*
- This combination is not typically seen in CKD-related mineral and bone disorder.
- While hypercalcemia can occur in some conditions, normal PTH with increased calcium often points toward conditions like **paraneoplastic syndromes** or **granulomatous diseases** producing PTH-related protein, or **vitamin D intoxication**.
*Increased PTH, increased calcium, decreased phosphate*
- This specific combination (high PTH, high calcium, low phosphate) is the classic hallmark of **primary hyperparathyroidism**.
- In contrast, secondary hyperparathyroidism due to CKD typically presents with **hypocalcemia** and **hyperphosphatemia** due to impaired renal function.
*Increased PTH, increased calcium, increased phosphate*
- This pattern is highly unusual and not characteristic of any common parathyroid or kidney disorder.
- While both PTH and phosphate can be increased in certain advanced stages of CKD, calcium levels are typically low or normal, not elevated in secondary hyperparathyroidism.
Question 24: A 23-year-old man presents to the office complaining of weight loss and fatigue for the past 2 months. He states that he has been experiencing foul-smelling, light-colored stools but thinks it is because he hasn’t been eating well, recently. He has a past medical history significant for cystic fibrosis, which is well-controlled medically. He denies any shortness of breath, chest or abdominal pain, nausea, vomiting, or melena. On physical examination, his skin is pale and dry. Which of the following would be the most likely etiology of a malabsorption syndrome giving rise to this patient’s current condition?
A. Decreased recycling of bile acids
B. Pancreatic insufficiency (Correct Answer)
C. Autoimmune damage to parietal cells
D. Chronic damage to intestinal mucosa
E. Damage to intestinal brush border
Explanation: ***Pancreatic insufficiency***
- Cystic fibrosis typically causes **exocrine pancreatic insufficiency** due to thick secretions blocking the pancreatic ducts, leading to malabsorption of fats and fat-soluble vitamins.
- **Foul-smelling, light-colored stools** (steatorrhea) are a classic symptom of fat malabsorption resulting from inadequate lipase production.
*Decreased recycling of bile acids*
- This typically results in **fat malabsorption**, but it is commonly associated with diseases affecting the **terminal ileum** (e.g., Crohn's disease, resection).
- While it can cause steatorrhea, it is not the primary or most common cause of malabsorption in cystic fibrosis.
*Autoimmune damage to parietal cells*
- This condition leads to **pernicious anemia** due to a lack of intrinsic factor and subsequent **vitamin B12 malabsorption**.
- It does not typically cause **steatorrhea** or generalized fat malabsorption, and it is not directly associated with cystic fibrosis.
*Chronic damage to intestinal mucosa*
- This points towards conditions like **celiac disease** or severe inflammatory bowel disease, which impair nutrient absorption through mucosal injury.
- While cystic fibrosis can have gastrointestinal manifestations, primary mucosal damage is not the leading cause of malabsorption, and the patient's symptoms are more consistent with fat malabsorption.
*Damage to intestinal brush border*
- This is characteristic of conditions like **lactase deficiency** or **celiac disease**, which affect the absorption of specific nutrients (e.g., carbohydrates).
- While it causes malabsorption, the patient's presentation with **steatorrhea** points more specifically to fat malabsorption, which is primarily due to pancreatic enzyme deficiency in cystic fibrosis.
Question 25: A healthy 30-year-old female has a measured creatinine clearance of 100 mL/min. She has a filtration fraction (FF) of 25%. Serum analysis reveals a creatinine level of 0.9 mg/dL and an elevated hematocrit of 0.6. Which of the following is the best estimate of this patient’s renal blood flow?
A. 1.2 L/min
B. 600 mL/min
C. 800 mL/min
D. 400 mL/min
E. 1.0 L/min (Correct Answer)
Explanation: ***1.0 L/min***
- The **renal plasma flow (RPF)** can be calculated by dividing the **creatinine clearance (which approximates GFR)** by the **filtration fraction (FF)**: RPF = GFR / FF = 100 mL/min / 0.25 = 400 mL/min.
- To find the **renal blood flow (RBF)**, we use the formula RBF = RPF / (1 - Hematocrit). Given RPF = 400 mL/min and Hematocrit = 0.6, RBF = 400 mL/min / (1 - 0.6) = 400 mL/min / 0.4 = 1000 mL/min, or **1.0 L/min**.
*1.2 L/min*
- This value would result if the hematocrit were lower (e.g., 0.5) or if the GFR or FF were different, leading to an incorrect RPF or RBF calculation.
- It does not align with the provided values when applying the standard physiological formulas relating GFR, FF, RPF, and hematocrit.
*600 mL/min*
- This value might be obtained if the hematocrit was significantly underestimated or if the RPF calculation was incorrect in determining the RBF.
- It arises from using an incorrect formula or misinterpreting the relationship between plasma flow and blood flow.
*800 mL/min*
- This result would occur if the calculation for RPF or the subsequent RBF was erroneous, possibly by using an incorrect denominator in the RBF formula.
- For example, if RPF was incorrectly assumed to be 320 mL/min and divided by 0.4 (1-Hematocrit).
*400 mL/min*
- This value represents the calculated **renal plasma flow (RPF)**, not the **renal blood flow (RBF)**.
- RBF is always higher than RPF because it includes both plasma and cellular components of blood.
Question 26: In a healthy patient with no renal abnormalities, several mechanisms are responsible for moving various filtered substances into and out of the tubules. Para-aminohippurate (PAH) is frequently used to estimate renal blood flow when maintained at low plasma concentrations. The following table illustrates the effect of changing plasma PAH concentrations on PAH excretion:
Plasma PAH concentration (mg/dL) | Urinary PAH concentration (mg/dL)
0 | 0
10 | 60
20 | 120
30 | 150
40 | 180
Which of the following mechanisms best explains the decreased rate of increase in PAH excretion observed when plasma PAH concentration exceeds 20 mg/dL?
A. Decreased glomerular filtration of PAH
B. Increased rate of PAH reabsorption
C. Increased flow rate of tubular contents
D. Saturation of PAH transport carriers (Correct Answer)
E. Increased diffusion rate of PAH
Explanation: ***Saturation of PAH transport carriers***
- PAH is primarily cleared by **tubular secretion** via organic anion transporters (OATs) in the proximal tubule, which have a **finite transport maximum (Tm)**.
- When plasma PAH concentration exceeds the capacity of these carriers (as seen above 20 mg/dL), the transporters become saturated, leading to a **decreased incremental excretion** despite rising plasma levels.
*Decreased glomerular filtration of PAH*
- **Glomerular filtration rate (GFR)** for PAH is proportional to its plasma concentration and is typically constant in a healthy kidney, so it would not decrease with increasing plasma PAH.
- A decrease in GFR would lead to a *reduced* overall excretion, but not specifically explain the *decreased rate of increase* at higher plasma concentrations.
*Increased rate of PAH reabsorption*
- PAH is **minimally reabsorbed** in the renal tubules; its primary mechanism of removal from the blood is active secretion.
- An increase in reabsorption would lead to *less* PAH in the urine, but there's no physiological basis for increased reabsorption as plasma concentration rises.
*Increased flow rate of tubular contents*
- While an increased flow rate can sometimes affect solute reabsorption or secretion, it would generally lead to a more, not less, efficient clearance of secreted substances.
- This mechanism does not explain the **saturation kinetics** observed with PAH at higher plasma concentrations.
*Increased diffusion rate of PAH*
- PAH is a charged organic anion, and its movement across tubular membranes is primarily mediated by **active transport** rather than simple diffusion.
- Even if diffusion played a minor role, an increased diffusion rate would generally lead to *more* excretion, not the observed plateau in the rate of increase.
Question 27: A 10-year-old boy is brought to a pediatric clinic by his parents with pain and weakness in the lower extremities for the past 3 weeks. The patient’s mother says that he has been active until the weakness and pain started during his soccer practice sessions. He says he also experiences muscle cramps, especially at night. His mother adds that, recently, the patient constantly wakes up in the night to urinate and is noticeably thirsty most of the time. The patient denies any recent history of trauma to his legs. His vaccinations are up to date and his family history is unremarkable. His vital signs are within normal limits. Physical examination is unremarkable. Laboratory findings are shown below:
Laboratory test
Serum potassium 3.3 mEq/L
Serum magnesium 1.3 mEq/L
Serum chloride 101 mEq/L
pH 7.50
Pco2 38 mm Hg
HCO3- 20 mEq/L
Po2 88 mm Hg
Which of the following is the most likely diagnosis in this patient?
A. Liddle syndrome
B. Conn’s syndrome
C. Fanconi syndrome
D. Gitelman’s syndrome (Correct Answer)
E. Bartter syndrome
Explanation: ***Gitelman's syndrome***
- The patient presents with **muscle weakness**, **cramps**, **polyuria**, and **polydipsia**, consistent with **hypokalemia (K+ 3.3 mEq/L)** and **hypomagnesemia (Mg 1.3 mEq/L)**.
- The **alkalotic pH (7.50)** with relatively preserved bicarbonate suggests **metabolic alkalosis** (though the HCO3- of 20 may reflect some renal compensation or mixed disorder).
- Gitelman's syndrome results from a defect in the **thiazide-sensitive Na-Cl cotransporter (NCCT)** in the **distal convoluted tubule**, leading to chronic salt wasting, hypokalemia, hypomagnesemia, and metabolic alkalosis.
- The **later age of presentation** (10 years old) and **normal blood pressure** are characteristic of Gitelman's syndrome, distinguishing it from Bartter syndrome (which typically presents earlier).
*Liddle syndrome*
- Presents with **hypertension**, **hypokalemia**, and **metabolic alkalosis** due to increased activity of the epithelial sodium channel (ENaC) in the collecting duct.
- The patient's **normal blood pressure** excludes this diagnosis.
*Conn's syndrome*
- Also known as **primary hyperaldosteronism**, characterized by **hypertension**, **hypokalemia**, and **metabolic alkalosis** from excessive aldosterone production.
- The **absence of hypertension** makes Conn's syndrome unlikely.
*Fanconi syndrome*
- Involves **generalized proximal tubular dysfunction** with wasting of glucose, amino acids, phosphate, bicarbonate, and other substances.
- Typically causes **metabolic acidosis** (from bicarbonate loss), not alkalosis, and would show evidence of **glycosuria** and **phosphaturia**.
- The specific pattern of isolated hypokalemia and hypomagnesemia with alkalosis does not fit Fanconi syndrome.
*Bartter syndrome*
- Disorder of the **thick ascending limb of the loop of Henle** with hypokalemia, metabolic alkalosis, and hyperreninemia.
- Typically presents in **infancy or early childhood** with more severe symptoms, failure to thrive, and **hypercalciuria** (leading to nephrocalcinosis).
- Gitelman's syndrome is distinguished by **later onset**, **milder symptoms**, **hypomagnesemia** (more prominent), and **hypocalciuria** rather than hypercalciuria.
Question 28: A 42-year-old man is brought to the emergency room because of confusion. His wife says he has been urinating more frequently than usual for the past 3 days. He has not had fever or dysuria. He has bipolar disorder, for which he takes lithium. His pulse is 105/min, and respirations are 14/min. He is lethargic and oriented only to person. Physical examination shows dry mucous membranes and increased capillary refill time. Laboratory studies show a serum sodium concentration of 158 mEq/L and an antidiuretic hormone (ADH) concentration of 8 pg/mL (N = 1–5). Which of the following is the most likely site of dysfunction in this patient?
A. Hypothalamic supraoptic nucleus
B. Descending loop of Henle
C. Juxtaglomerular apparatus
D. Collecting duct (Correct Answer)
E. Posterior pituitary gland
Explanation: ***Collecting duct***
- The patient presents with **hypernatremia** (Na 158 mEq/L), **polyuria**, and **dehydration** (dry mucous membranes, increased capillary refill time, confusion), indicative of **nephrogenic diabetes insipidus**.
- His ADH level is **elevated** (8 pg/mL), suggesting that the kidneys are not responding to ADH; the **collecting ducts** are the primary site where ADH exerts its effect via aquaporin-2 channels to reabsorb water.
- **Lithium**, which this patient is taking for bipolar disorder, is a well-known cause of nephrogenic diabetes insipidus by interfering with ADH action at the collecting duct level.
*Hypothalamic supraoptic nucleus*
- This nucleus is responsible for synthesizing **ADH**. Dysfunction here would lead to **decreased ADH production** (central diabetes insipidus), but the patient's ADH level is elevated.
- A lack of ADH from this area would not explain the kidney's unresponsiveness to the high ADH levels observed.
*Descending loop of Henle*
- The descending loop of Henle is permeable to water but not directly responsible for ADH-mediated water reabsorption that is impaired in diabetes insipidus.
- Its primary role is to concentrate the filtrate as it descends into the hypertonic medulla.
*Juxtaglomerular apparatus*
- The juxtaglomerular apparatus regulates **blood pressure** and **glomerular filtration rate** through the **renin-angiotensin-aldosterone system**.
- While important for kidney function, it's not directly involved in the ADH-mediated water reabsorption whose impairment leads to nephrogenic diabetes insipidus.
*Posterior pituitary gland*
- This gland stores and releases ADH, which is synthesized in the hypothalamus.
- If the posterior pituitary were dysfunctional, it would lead to **decreased ADH release** (central diabetes insipidus), contradicting the patient's **elevated ADH level**.
Question 29: An investigator is studying physiologic renal responses to common medical conditions. She measures urine osmolalities in different parts of the nephron of a human subject in the emergency department. The following values are obtained:
Portion of nephron Osmolality (mOsmol/kg)
Proximal convoluted tubule 300
Loop of Henle, descending limb 1200
Loop of Henle, ascending limb 250
Distal convoluted tubule 100
Collecting duct 1200
These values were most likely obtained from an individual with which of the following condition?
A. Gitelman syndrome
B. Psychogenic polydipsia
C. Furosemide overdose
D. Dehydration (Correct Answer)
E. Diabetes insipidus
Explanation: ***Dehydration***
- The high osmolality in the **collecting duct (1200 mOsmol/kg)** indicates the kidney is actively conserving water, a normal physiological response to **dehydration**.
- In dehydration, **antidiuretic hormone (ADH)** levels are high, leading to increased water reabsorption in the collecting ducts and thus a concentrated urine.
*Gitelman syndrome*
- This condition involves a defect in the **NaCl cotransporter** in the **distal convoluted tubule**, leading to impaired sodium reabsorption.
- Patients typically present with significant **hypokalemia**, metabolic alkalosis, and a relatively dilute urine, which is not consistent with the given osmolality values.
*Psychogenic polydipsia*
- Individuals with psychogenic polydipsia consume excessive amounts of water, leading to **dilute urine** (low urine osmolality) as a compensatory mechanism to excrete the excess water.
- This would result in much lower osmolality values throughout the nephron, particularly in the collecting duct, compared to the values provided.
*Furosemide overdose*
- Furosemide is a **loop diuretic** that inhibits the reabsorption of sodium and chloride in the **thick ascending limb of the loop of Henle**.
- This would impair the kidney's ability to concentrate urine, leading to a much **lower osmolality in the collecting duct** than observed in this scenario.
*Diabetes insipidus*
- Diabetes insipidus (DI) is characterized by either a deficiency in ADH (central DI) or unresponsiveness to ADH (nephrogenic DI).
- In both types, the kidney cannot concentrate urine effectively, resulting in the production of a **large volume of very dilute urine** (low urine osmolality, typically <300 mOsmol/kg), which contradicts the high collecting duct osmolality.
Question 30: An investigator is studying the efficiency of a new anti-gout drug in comparison to colchicine in an experimental animal model. The test group of animals is injected with the new drug, while the control group receives injections of colchicine. Which of the following cellular functions will most likely be impaired in the control subjects after the injection?
A. Nutrient absorption
B. Muscle contraction
C. Axonal transport (Correct Answer)
D. Intercellular adhesion
E. Stereocilia function
Explanation: ***Axonal transport***
- **Colchicine** is a potent inhibitor of **microtubule polymerization**, which are essential components of the cytoskeleton.
- **Axonal transport** heavily relies on microtubules as tracks for motor proteins (kinesin and dynein) to move vesicles and organelles, and its impairment by colchicine directly affects this process.
*Nutrient absorption*
- While colchicine can cause gastrointestinal side effects like **diarrhea** and **malabsorption** due to its effect on rapidly dividing gut epithelial cells, it's not its primary or most direct cellular function impairment.
- Nutrient absorption itself involves many processes, including membrane transport proteins and microvilli, which are less directly affected by microtubule disruption compared to axonal transport.
*Muscle contraction*
- **Muscle contraction** is primarily mediated by the interaction of actin and myosin filaments within the **sarcomere**, which are not directly targeted by colchicine's microtubule inhibition.
- While microtubules play a minor role in muscle structure, their inhibition by colchicine does not directly hinder the contractile machinery itself.
*Intercellular adhesion*
- **Intercellular adhesion** is primarily mediated by cell adhesion molecules such as **cadherins**, **integrins**, and **selectins**, and anchored by structures like desmosomes and tight junctions.
- These structures are composed of actin and intermediate filaments, and are not directly dependent on microtubules for their primary function.
*Stereocilia function*
- **Stereocilia** in hair cells of the inner ear are primarily composed of **actin filaments**, not microtubules.
- Therefore, colchicine's effect on microtubules would not directly or significantly impair stereocilia function.